Last reviewed · How we verify

NCT04906889

the Effect of Dexmedetomidine and Licodaine on Acute Postoperative Pain in Gynecological Laparoscopy

Withdrawn NA Last updated 12 January 2023
What this trial tests

NA trial testing Dexmedetomidine Hydrochloride in Gynecologic Disease. Withdrawn.

Timeline
1 June 2021
Primary endpoint
30 May 2022
1 June 2022

Quick facts

Lead sponsorThe Catholic University of Korea
PhaseNA
StatusWithdrawn
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingtriple
Primary purposesupportive care
Start date1 June 2021
Primary completion30 May 2022
Estimated completion1 June 2022
Sites2 locations across South Korea

Drugs / interventions tested

Conditions studied

Sponsor

The Catholic University of Korea

Who can join

Adults 20 to 70, female only, with Gynecologic Disease. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The aim of this study is to investigate the effect of opioid-free anesthesia using dexmedetomidine and lidocaine instead of remifentanil infusion, on the acute postoperative pain after the gynecological laparoscopy

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Dexmedetomidine Hydrochloride

Trials testing the same drug.

Other recruiting trials for Gynecologic Disease

Currently open trials in the same condition.

Other The Catholic University of Korea trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04906889.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing